References
- Aronow WS. Why and how we should treat elderly patients with hypertension? Curr Vasc Pharmacol. 2010;8:780–787.
- Aronow WS, Fleg JL, Pepine CJ, Artinian NT, Bakris G, Brown AS, . ACCF/AHA 2011 expert consensus document on hypertension in the elderly: A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol. 2011;57: 2037–2114.
- Aronow WS, Fleg JL, Pepine CJ, Artinian NT, Bakris G, Brown AS, . ACCF/AHA 2011 expert consensus document on hypertension in the elderly: A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. Circulation. 2011; 123:2434–2506.
- Lloyd-Jones D, Adams R, Carnethon M, De Simone G, Ferguson B, Flegal K, . Heart disease and stroke statistics – 2009 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2009;119:e21–e181.
- Fleg JL, Aronow WS, Frishman WH. Cardiovascular drug therapy in the elderly: Benefits and challenges. Nat Rev Cardiol. 2011;8:13–28.
- Aronow WS, Ahmed MI, Ekundayo OJ, Allman RM, Ahmed A. A propensity-matched study of the association of peripheral arterial disease with cardiovascular outcomes in community-dwelling older adults. Am J Cardiol. 2009;103: 130–135.
- Beckett NS, Peters R, Fletcher AE, Staessen JA, Liu L, Dumitrascu D . Treatment of hypertension in patients 80 years of age or older. N Engl J Med. 2008;358:1887–1898.
- Lloyd-Jones DM, Evans JC, Levy D. Hypertension in adults across the age spectrum: Current outcomes and control in the community. JAMA. 2005;294:466–472.
- Gandelman G, Aronow WS, Varma R. Prevalence of adequate blood pressure control in self-pay or Medicare patients versus Medicaid or private insurance patients with systemic hypertension followed in a university cardiology or general medicine clinic. Am J Cardiol. 2004;94:815–816.
- Appel LJ, Espeland MA, Easter L, Wilson AC, Folmar S, Lacy CR. Effects of reduced sodium intake on hypertension control in older individuals: Results from the Trial of Nonpharmacologic Interventions in the Elderly (TONE). Arch Intern Med. 2001;161:685–693.
- Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, . The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and treatment of High Blood Pressure: The JNC 7 report. JAMA. 2003;289:2560–2572.
- Bielecka-Dabrowa A, Aronow WS, Rysz J, Banach M. Current place of beta-blockers in the treatment of hypertension. Curr Vasc Pharmacol. 2010;8:733–741.
- Turnbull F, Neal B, Ninomiya T, Algert C, Barzi F, Bulpitt C, . Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: Meta-analysis of randomised trials. Br Med J. 2008;336: 1121–1123.
- Mancia G, Laurent S, Agabiti-Rosei E, Ambrosioni E, Burnier M, Caulfield MJ, . Reappraisal of European guidelines on hypertension management: A European Society of Hypertension Task force document. Blood Press. 2009;18:308–347.
- Law MR, Morris JK, Wald NJ. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: Meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. Br Med J. 2009; 338:1665–1683.
- Banach M, Michalska M, Kjeldsen SE, Malyszko J1, Mikhailidis DP, Rysz J. What should be the optimal levels of blood pressure: Does the J-curve phenomenon really exist? Expert Opin Pharmacother. 2011;DOI:10.1517/14656566.2011.579106.